Search research articles
Contact Us
Filters
Showing results (141-150 of 176) with videos related to
Page
of 18
Sort By:
AIDS (London, England)
|
May 14, 2016
Proteomic profiling of pretreatment serum from HIV-infected patients identifies candidate markers predictive of lymphoma development
Maja Ølholm Vase, Maja Ludvigsen, Knud Bendix, et al.
AIDS (London, England)
|
April 28, 2011
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study
Jean-Paul Viard, Jean-Claude Souberbielle, Ole Kirk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 5, 2022
Bacteremia With Anaerobic Bacteria and Association With Colorectal Cancer: A Population-based Cohort Study
Ulrik S Justesen, Stig L Nielsen, Thøger G Jensen, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
December 23, 2011
Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls
Court Pedersen, Morten Breindahl, Naresh Aggarwal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 20, 2014
Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users
Zitta Barrella Harboe, Mette Vang Larsen, Steen Ladelund, et al.
Basic & Clinical Pharmacology & Toxicology
|
October 4, 2007
Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trials
Ulrik S Justesen, Zoe Fox, Court Pedersen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 22, 2010
Nonresponder patients with hepatitis C virus genotype 2/3 infection: a question of low systemic interferon concentrations?
Asa Alsiö, Peer Brehm Christensen, Martti Färkkilä, et al.
Plos One
|
September 7, 2012
Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection
Elizabeth Hamlyn, Fiona M Ewings, Kholoud Porter, et al.
Plos One
|
January 19, 2012
Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3
Karolina Rembeck, Asa Alsiö, Peer Brehm Christensen, et al.
AIDS (London, England)
|
May 6, 2016
Associations between HIV-RNA-based indicators and virological and clinical outcomes
Kamilla G Laut, Leah C Shepherd, Court Pedersen, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 176) with videos related to
Sort By:
Page
of 18
AIDS (London, England)
|
May 14, 2016
Proteomic profiling of pretreatment serum from HIV-infected patients identifies candidate markers predictive of lymphoma development
Maja Ølholm Vase, Maja Ludvigsen, Knud Bendix, et al.
AIDS (London, England)
|
April 28, 2011
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study
Jean-Paul Viard, Jean-Claude Souberbielle, Ole Kirk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 5, 2022
Bacteremia With Anaerobic Bacteria and Association With Colorectal Cancer: A Population-based Cohort Study
Ulrik S Justesen, Stig L Nielsen, Thøger G Jensen, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
December 23, 2011
Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls
Court Pedersen, Morten Breindahl, Naresh Aggarwal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 20, 2014
Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users
Zitta Barrella Harboe, Mette Vang Larsen, Steen Ladelund, et al.
Basic & Clinical Pharmacology & Toxicology
|
October 4, 2007
Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trials
Ulrik S Justesen, Zoe Fox, Court Pedersen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 22, 2010
Nonresponder patients with hepatitis C virus genotype 2/3 infection: a question of low systemic interferon concentrations?
Asa Alsiö, Peer Brehm Christensen, Martti Färkkilä, et al.
Plos One
|
September 7, 2012
Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection
Elizabeth Hamlyn, Fiona M Ewings, Kholoud Porter, et al.
Plos One
|
January 19, 2012
Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3
Karolina Rembeck, Asa Alsiö, Peer Brehm Christensen, et al.
AIDS (London, England)
|
May 6, 2016
Associations between HIV-RNA-based indicators and virological and clinical outcomes
Kamilla G Laut, Leah C Shepherd, Court Pedersen, et al.
Page
of 18